However, to accurately stage those patients without obvious lymph node or bone involvement, to differentiate BPH or prostatitis from early stage or PSMA-negative prostate cancer, pelvic PET/MR is required mainly because of the high soft tissue resolution of MR (20). This evidence concerns the gene FOLH1 and prostatitis.